Emfret公司血小板消除抗體R300說明書
Antibodies for Platelet Depletion in Mice
# R300 |
|
|
|
產品資料 |
|
貨號 | R300 |
同種型(isotype) | 大鼠IgG (Wistar) |
含量 | 0.5 mg purified immunoglobulins in PBS, sterile filtered |
包裝 | 1ML |
濃度 | 0.5 mg/ml |
本產品只用于科研，不用于診斷，也不屬于醫(yī)療用品
特異性: This antibody preparation contains a mixture of purified rat monoclonal antibodies directed
against mouse GPIba (CD42b). Targeting of this receptor with divalent IgGs results in profound and
irreversible Fc-independent plaet depletion in mice1,2. Plaet depletion is frequently used to study
the general role of plaets in (patho-) physiology3.
制備 : 抗體是雜交瘤細胞上清通過G-Sepharose純化所得，內毒素含量小于 0.0025 EU/µg
保存和運輸：4度保存和運輸，保質期為6個月 ，無菌保存不含防腐劑，分裝保存-20度至少可以保存一年以上，但請避免反復凍融
使用方法: 按動物體重注射抗體，用 量為2 µg抗體/g動物體重，可以參見上圖。如果4 µg抗體/g動物體重，可以持續(xù)更長時間。注射后60分鐘內可以去除血小板95%以上，建議每次注射100-200µL抗體（用無菌PBS稀釋）。詳情聯系靶點科技技術支持。可以聯合清除巨噬細胞（LIPOSOMA，CP-005-005）和中性粒細胞，咨詢綜合解決方案。
引用文獻:
1. Bergmeier W, Rackebrandt K, Schroder W, Zirngibl H, Nieswandt B. (2000) Structural and functional characterization of the mouse von Willebrand
factor receptor GPIb-IX with novel monoclonal antibodies. Blood. 95:886-93.
2. Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, and Zirngibl H. (2000) Identification of critical antigen-specific mechanisms in the
development of immune thrombocytopenic purpura in mice. Blood. 96:2520-27.
3. Elzey BD, Tian J, Jensen RJ et al. (2003) Plaet-mediated modulation of adaptive immunity. A communication link between innate and adaptive
immune compartments. Immunity.19:9-19.
